Skip to main content
See every side of every news story
Published loading...Updated

FDA denies Lantheus’ application for new PET imaging agent

The Bedford, Massachusetts-based manufacturer has for months sought to roll out LNTH-2501—a radioactive diagnostic kit for localizing neuroendocrine tumors.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

radiologybusiness.com broke the news on Monday, June 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal